Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 9Thoracic 3Head & Neck 2Gynecologic 2Genitourinary 2Sarcoma 1Gastrointestinal 1Dermatologic 1CNS 1Breast 1

Conditions

Ovarian Neoplasms 323Fallopian Tube Neoplasms 159Carcinoma, Ovarian Epithelial 114Endometrial Neoplasms 77Uterine Cervical Neoplasms 72Neoplasms 28Carcinoma, Non-Small-Cell Lung 24Breast Neoplasms 23Brenner Tumor 21Recurrence 19Testicular Neoplasms 17Peritoneal Neoplasms 17Stomach Neoplasms 14Neoplasm Metastasis 12Triple Negative Breast Neoplasms 11Urinary Bladder Neoplasms 10Testicular Germ Cell Tumor 10Sarcoma 10Pancreatic Neoplasms 10Lung Neoplasms 10Colorectal Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Parkinson Disease 4, Autosomal Dominant Lewy Body 9Teratoma 8Ovarian Germ Cell Cancer 8Neuroectodermal Tumors, Primitive, Peripheral 8Central Nervous System Neoplasms 8Uterine Neoplasms 7Small Cell Lung Carcinoma 7Melanoma 7

Interventions

Trastuzumab 2Taxes 2Filgrastim 2Carboplatin 2veliparib 1tislelizumab 1tipifarnib 1spartalizumab 1etoposide phosphate 1entinostat 1Quality of Life 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Patient Reported Outcome Measures 1Paclitaxel 1Oxaliplatin 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Leucovorin 1Interleukin-12 Subunit p35 1Interleukin-12 1Immunotherapy 1Immunohistochemistry 1Ifosfamide 1Genetic Profile 1Gene Expression Profiling 1Gemcitabine 1Fluorodeoxyglucose F18 1Floxuridine 1FAPI-46 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms, Unknown Primary × Carboplatin × Gynecologic × Clear all
NCT01366144 2026-04-13

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

National Cancer Institute (NCI)

Phase 1 Active not recruiting
94 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Breast Neoplasms, Carcinoma, Transitional Cell, Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Unknown Primary, Ovarian Neoplasms, Testicular Neoplasms, Endometrial Neoplasms, Liver Failure, Renal Insufficiency

NCT00003657 2017-01-20

High-dose ICE With Amifostine

Dana-Farber Cancer Institute

Phase 2 Completed
24 enrolled
CNSGenitourinaryGynecologicHead & NeckSarcomaThoracic

AIDS-related Kaposi sarcoma, Testicular Germ Cell Tumor, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Unknown Primary, Ovarian Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡